Kamal Syed T 4
4 · American Renal Associates Holdings, Inc. · Filed Jun 3, 2020
Insider Transaction Report
Form 4
Kamal Syed T
DirectorPresident
Transactions
- Exercise/Conversion
Common Stock
2020-06-01$1.28/sh+208,360$266,701→ 1,192,290 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-01−208,360→ 0 totalExercise: $1.28Exp: 2020-07-09→ Common Stock (208,360 underlying) - Exercise/Conversion
Common Stock
2020-06-01$1.28/sh+208,360$266,701→ 983,930 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-01−208,360→ 0 totalExercise: $1.28Exp: 2020-07-09→ Common Stock (208,360 underlying)
Footnotes (3)
- [F1]Reflects the exercise of options that were otherwise set to expire on July 9, 2020.
- [F2]An option that vested upon the attainment by Centerbridge Capital Partners, L.P. and certain of its affiliates (together, "Centerbridge") of both a 2.5 times return on investment ("MOIC") and a 20% internal rate of return ("IRR").
- [F3]An option that vested upon the attainment by Centerbridge of both a 3.0 times MOIC and a 25% IRR.